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Most current articleSUMMARY
Enteric glia monitor neurotransmission in the gut but the
signiﬁcance of glial activity has remained unclear. We found
that selectively triggering glial activity has the potential to
drive excitatory neural programs that control gut motility.
BACKGROUND & AIMS: Gastrointestinal motility is regulated
by enteric neural circuitry that includes enteric neurons and
glia. Enteric glia monitor synaptic activity and exhibit responses
to neurotransmitters that are encoded by intracellular calcium
(Ca2þ) signaling. What role evoked glial responses play in the
neural regulation of gut motility is unknown. We tested how
evoking Ca2þ signaling in enteric glia affects the neural control
of intestinal motility.
METHODS: We used a novel chemogenetic mouse model that
expresses the designer receptor hM3Dq under the transcrip-
tional control of the glial ﬁbrillary acidic protein (GFAP) pro-
moter (GFAP::hM3Dq mice) to selectively trigger glial Ca2þ
signaling. We used in situ Ca2þ imaging and immunohisto-
chemistry to validate this model, and we assessed gut motility
by measuring pellet output and composition, colonic bead
expulsion time, small intestinal transit time, total gut transit
time, colonic migrating motor complex (CMMC) recordings, and
muscle tension recordings.
RESULTS: Expression of the hM3Dq receptor is conﬁned to
GFAP-positive enteric glia in the intestines of GFAP::hM3Dq
mice. In these mice, application of the hM3Dq agonist cloza-
pine-N-oxide (CNO) selectively triggers intracellular Ca2þ re-
sponses in enteric glia. Glial activation drove neurogenic
contractions in the ileum and colon but had no effect on
neurogenic relaxations. CNO enhanced the amplitude and fre-
quency of CMMCs in ex vivo preparations of the colon, and CNO
increased colonic motility in vivo. CNO had no effect on the
composition of fecal matter, small intestinal transit, or whole
gut transit.
CONCLUSIONS: Glial excitability encoded by intracellular Ca2þ
signaling functions to modulate excitatory enteric circuits.
Selectively triggering glial Ca2þ signaling might be a novel
strategy to improve gut function in motility disorders. (Cell Mol
Gastroenterol Hepatol 2015;1:631–645; http://dx.doi.org/
10.1016/j.jcmgh.2015.08.004)© 2015 The Authors. Published by Elsevier Inc. on behalf of the AGA
Institute. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Intestine; Gut.ntestinal functions such as peristalsis require the coor-Idinated activity of multiple cell types throughout the gut
wall, including enteroendocrine cells, nerves, interstitial cells,
and smooth muscle.1 Yet deciphering the exact contribution
of individual cell types is extremely challenging because of
the complex nature of tissue and the overlapping expression
of many signaling molecules. Each cell type in the chain
of command from mucosa to smooth muscle is clearly
essential for the transduction of luminal cues into motor
responses, and the ultimate integration and execution of mo-
tor patterns depends on the neural circuitry within the enteric
nervous system (ENS).2 However, the exact roles of many
classes of cells in the gut wall is still highly debated.3–5
One class of cells that have gained particular interest
recently are the enteric glia.5 These astrocyte-like periph-
eral glial cells surround enteric neurons and play important
roles in the maintenance of enteric neurocircuits. Indeed,
enteric glia are tuned to detect neuronal activity6–11 and
express receptors for all major classes of enteric neuro-
transmitters.12 New data showing that enteric glia are
activated by speciﬁc neural pathways13 and during physio-
logic patterns of ENS activity 9 raise the possibility that glial
activity may be involved in the modulation of ENS circuits in
addition to supporting neuronal health.14–16 In support,
impairing glial functions with a metabolic toxin17 or the
selective genetic ablation of glial channels involved in
intercellular communication impairs gut motility.18 These
studies suggest that glial functions are necessary for the
maintenance of gut motility, but whether the observed
changes reﬂect poor glial metabolic support of neurons or a
change in active glial signaling is not known.
Most enteric glial receptors for neuroactive compounds
are G protein-coupled receptors (GPCRs) and many of these
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cades that lead to elevations in intracellular Ca2þ.8 These
intracellular Ca2þ responses are largely considered central
to many glial functions and are currently used as the main
readout of glial activity10 but the signiﬁcance of glial Ca2þ
responses remains a matter of great debate.19 Thus, despite
intense research investigating glial responsiveness to various
mediators, major questions remain unresolved concerning
the physiological signiﬁcance glial Ca2þ responses and what
information enteric glial Ca2þ responses encode.
New technologies have emerged in recent years that
permit the activational control of individual populations of
cells in complex tissue.20,21 Importantly, these noninvasive
techniques can be employed in vivo or in intact organs to
assess the function of speciﬁc signaling pathways in deﬁned
cell populations such as enteric glia. Here, we used a che-
mogenetic approach to selectively trigger a glial Gq–GPCR
signal cascade leading to intracellular Ca2þ responses22 to
determine the effect of glial Ca2þ-dependent signaling on
the neural control of gut motility in vivo and ex vivo. Our
results show that Ca2þ-dependent activity within glial cells
has a major effect on excitatory neuromuscular trans-
mission in the colon and that the selective activation of Ca2þ
signaling in glial cells drives neurogenic contractions.
Importantly, our data provide the ﬁrst conclusive evidence
of active glial regulation of enteric neurotransmission. In
addition, our ﬁndings raise the possibility that the selective
modulation of glial cells could be a novel therapeutic
approach to improve gut motility in functional gastrointes-
tinal disorders such as slow transit constipation.
Materials and Methods
Animals
All experimental protocols were approved by the Mich-
igan State University Institutional Animal Care and Use
Committee (IACUC). The GFAP::hM3Dq transgenic mice were
a gift from Dr. Ken McCarthy (University of North Carolina
at Chapel Hill) and were bred for experiments as hetero-
zygotes at Michigan State University.23 The GFAP::tTA mice
(lines 67, 78, and 110) were a gift from Dr. Brian Popko24Table 1.Details of Primary and Secondary Antibodies
Antibody
Primary antibodies
Goat anti-c-Kit R&D Systems, Min
Chicken anti-GFAP Abcam, Cambridg
Rabbit anti-HA Cell Signaling Tec
Invitrogen, Carlsb
Anti-human Hu C/D Molecular Probes,
Rabbit anti-S100beta Abcam, Cambridg
Secondary antibodies
Goat anti-rabbit Alexa Fluor 488 Invitrogen
Donkey anti-goat Alexa Fluor 568 Invitrogen
Goat anti-chicken Alexa Fluor 568 Invitrogen
Goat anti-rabbit Alexa Fluor 568 Invitrogen
Streptavidin conjugated Alexa Fluor 594 Jackson ImmunoR
RRID, Research Resource Identiﬁers, Antibody Registry (http://(University of Chicago) and were bred with tetO::hM3Dq
mice [Tg(tetO-CHRM3*)1Blr/J; Jackson Laboratory, Bay
Harbor, MA; RRID: IMSR_JAX:014093] at Michigan State
University to obtain double transgenic mice. Mice of both
sexes, aged 8–12 weeks, were used for experiments and
wild-type (WT) littermates served as experimental controls.
Genotyping was performed by the Research Technology
Support Facility at Michigan State University. The mice were
maintained in a temperature-controlled environment on a
12-hour light/dark cycle, with access to tap water and
regular chow ad libitum.Whole-Mount Immunohistochemistry
Whole-mount preparations of the ileal and colonic
myenteric plexus were prepared from Zamboni’s-ﬁxed tis-
sue and processed for immunohistochemical analysis with
the antibodies shown in Table 1 as previously described
elsewhere.25 Brieﬂy, ﬁxed tissue was pinned ﬂat in a Sylgard
(Dow-Corning, Midland, MI)-coated Petri dish, and the mu-
cosa, submucosa, and circular muscle were removed with
forceps to expose the myenteric plexus. The resulting lon-
gitudinal muscle myenteric plexus (LMMP) tissue prepara-
tions underwent three 10-minute washes in 0.1% Triton
X-100 in phosphate-buffered saline (PBS-Triton) followed
by a 45-minute incubation in blocking solution (containing
4% normal goat or normal donkey serum, 0.4% Triton
X-100 and 1% bovine serum albumin). Preparations were
incubated in primary antibodies overnight at room temper-
ature and secondary antibodies for 2 hours at room tem-
perature (in blocking solution) before mounting. Dual-
labeling with antibodies raised in the same host was per-
formed using a horseradish peroxidase–goat anti-rabbit IgG
and Alexa Fluor 568 tyramide signal ampliﬁcation kit (Life
Technologies, Grand Island, NY) following the manufacturer’s
instructions. Images were acquired through the 20 [Plan-
Fluor, 0.75 numerical aperture (n.a.)] objective of an upright
epiﬂuorescence microscope (Nikon Eclipse Ni; Nikon, Mel-
ville, NY) with a Retiga 2000R camera (QImaging, Surrey, BC,
Canada) controlled by QCapture Pro 7.0 (QImaging) or
through the 60 (Plan-Apochromat, 1.42 n.a.) oil-immersionSource Dilution RRID
neapolis, MN 1:200 AB_354750
e, MA 1:1000 AB_304558
hnology, Danvers, MA 1:500 AB_1549585
ad, CA 1:250 AB_87935
Eugene, OR 1:200 AB_1500232
e, MA 1:2000 AB_882426
1:400 AB_10562715
1:400 AB_10564097
1:400 AB_10584483
1:400 AB_10563566
esearch, West Grove, PA 1:400 AB_2337250
antibodyregistry.org).
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scope (Olympus, Center Valley, PA).
Calcium Imaging
Live whole-mounts of the ileal and colonic myenteric
plexus were prepared for Ca2þ imaging as described by
Fried and Gulbransen.26 Brieﬂy, distal ileal and colonic
segments were collected in ice-cold Dulbecco’s modiﬁed
Eagle medium (DMEM) and transferred to Sylgard-coated,
open diamond shaped bath recording chambers and then
opened along the mesenteric border, pinned ﬂat, and
microdissected. LMMP preparations were incubated for 15
minutes at room temperature in an enzyme mixture con-
sisting of 150 U/mL Collagenase type II and 1 U/mL Dispase
(Life Technologies) dissolved in DMEM before gentle tritu-
ration. LMMPs were loaded in the dark for 45 minutes at
37C (5% CO2, 95% air) with 4 mM Fluo-4 AM, 0.02%
Pluronic F-127 and 200 mM water-soluble Probenecid (Life
Technologies) in DMEM. LMMPs were washed three times
with DMEM and incubated with 200 mM probenecid in
DMEM 15 minutes to de-esterify before imaging. Images
were acquired every 1–2 seconds (s) through the 40
water-immersion objective (LUMPlan N, 0.8 n.a.) of an up-
right Olympus BX51WI ﬁxed-stage microscope (Olympus,
Tokyo, Japan) using IQ2 software and a Neo sCMOS camera
(Andor, South Windsor, CT). Whole mounts were super-
fused with Krebs buffer (37C) at 2–3 mL min1.
Contractility Studies
Isometric muscle tension recordings were performed in
longitudinally–oriented segments of distal colon and ileum
under 1 g passive tension. Muscle strips were afﬁxed to a
force transducer (Grass Instruments, Quincy, MA) between
two platinum electrodes for electrical ﬁeld stimulation
(EFS) and data was charted with Labscribe (iWorx, Dover,
NH) as described previously elsewhere.18 Responses were
normalized to an initial bethanechol (BCH, 10 mM, cholin-
ergic muscarinic agonist)-induced contraction. Neurogenic
contractions and relaxations were induced by application of
EFS (20V, 0.1 milliseconds, 2–30 Hz). Neurogenic re-
laxations were studied in tissues precontracted with 5 mM
prostaglandin F2-a (PGF2a). Relaxations were induced when
the contractile response to PGF2a was stable for at least
5 minutes. Tetrodotoxin (TTX, 0.3 mM, voltage-gated sodium
channel inhibitor) was applied to block neurogenic
responses.
Colonic Migrating Motor Complexes
Colonic migrating motor complexes (CMMCs) were
recorded from intact colons ex vivo as previously described
elsewhere.27 Colons were collected in warmed media and
luminal contents were gently ﬂushed. A stainless-steel rod
was inserted into the lumen, and the tissue was secured at
both ends with surgical silk. Force transducers (Grass In-
struments) were placed 2 cm apart and attached to the oral
and aboral ends by surgical silk. Tissue was placed into a
bath containing DMEM-F12 media (37C) and adjusted to an
initial tension of 0.5 g. CMMCs were recorded with LabChart8 (ADInstruments, Colorado Springs, CO) for 20 minutes
following an acclimation period and the initial 6-minute
interval was used as baseline. Agonists were bath applied
and CMMCs recorded for an additional 6-minute interval.
CMMCs were deﬁned as a complex in which contraction
occurs ﬁrst at the oral site followed by a contraction at the
aboral site. Amplitude, integral, frequency, and propagation
velocity were calculated as percent of baseline.
Colon Bead Assay
Distal colonic transit was assessed by measuring the
latency to expel a small (2 mm diameter) plastic bead
inserted 3 cm into the colon.18
Endogenous Pellet Production
Mice were individually housed, and fecal pellet output
was measured on 2 consecutive days. Pellets were collected
for 1 hour beginning at 9:00 AM (Zeitgeber þ3). The wet
weight of fecal matter was measured immediately, and the
dry weight was obtained the next day after dehydration.18
Data from the 2 days was averaged.
Whole Gut Transit
Total intestinal transit time was deﬁned as the latency
from gavage of 0.2 mL of a 6% carmine red solution in H2O
with 0.5% methylcellulose to the appearance of red dye in
fecal pellets.18
Upper Gastrointestinal Transit
Upper gastrointestinal transit was assessed as described
previously.28 Brieﬂy, mice received a gavage of 0.2 mL of a
6% carmine red solution in H2O with 0.5% methylcellulose.
Mice were euthanized 15 minutes later, and the distance
travelled was measured to calculate upper gastrointestinal
velocity.
Solutions
Calcium imaging experiments were performed in modi-
ﬁed Krebs buffer consisting of (in mmol/L): 121 NaCl, 5.9
KCl, 2.5 CaCl2, 1.2 MgCl2, 1.2 NaH2PO4, 10 HEPES, 21.2
NaHCO3, 1 pyruvic acid, 8 glucose (pH adjusted to 7.4 with
NaOH) with 3 mmol/L nicardipine and 1 mmol/L scopol-
amine to inhibit muscle contractions. Muscle contractility
studies were performed in normal Krebs buffer consisting of
(in mmol/L): 117 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgCl2, 1.2
NaH2PO4, 25 NaHCO3 and 11 glucose. CMMC studies were
conducted in DMEM/Nutrient Mixture F-12 (Life Technol-
ogies) supplemented with L-glutamine and HEPES.
Chemicals and Reagents
Unless otherwise listed, all chemicals and reagents were
purchased from Sigma-Aldrich (St. Louis, MO). Clozapine-N-
oxide (CNO) was obtained from the National Institute on
Drug Abuse Drug Supply Program at the National Institutes
of Health and bath applied at 10 mM for isolated prepara-
tions or administered via an intraperitoneal injection at
0.25 mg kg1 for in vivo experiments. Drugs were bath
Figure 1. Selective expression of hM3Dq receptors by enteric glia in the intestine of GFAP::hM3Dq mice. (A) Model of
experimental paradigm used in this study. (B) Schematic of transgene containing hemagglutinin (HA)-tagged hM3Dq driven by
the glial ﬁbrillary acidic protein (GFAP) promoter. (C–G) Confocal images of dual-label immunohistochemistry for the HA-
tagged hM3Dq protein (green in all panels at left) and enteric glia (C–E center; GFAP immunoreactivity and S100beta
immunoreactivity shown in magenta), enteric neurons (F center; HuC/D immunoreactivity shown inmagenta) or interstitial cells
of Cajal (ICCs) (G center; c-Kit immunoreactivity shown in magenta) in the myenteric plexus of GFAP::hM3Dq mice. Overlays
are shown in right-hand panels. The images in C and G are z-stacks and the images in D–F are a single optical slice (1 mm). The
dashed line in G denotes the boundary of a myenteric ganglion that lies on top of ICCs and smooth muscle cells. Note that HA-
immunoreactivity covers the surface of GFAP-immunoreactive (C, D) and S100beta-immunoreactive (E) enteric glial cells and
does not localize with enteric neurons (F) or ICCs (G). Also note that no HA-immunoreactivity is present within the smooth
muscle coats (G). Images are representative of labeling in a minimum of 9 animals. Scale bars in C, D: 10 mm; scale bar in C
applies to panels C, E, and F; scale bar in G is 20 mm.
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experiments and directly added to organ baths for isometric
muscle tension recordings and CMMC recordings. Thus,
there is a lag between drug application and cellular
response in Ca2þ imaging experiments that is not present in
organ baths because of the time required for the drug to
reach the tissue through the perfusion system.Statistical Analysis
Digital images were analyzed ofﬂine using ImageJ
software (National Institutes of Health, Bethesda, MD).
Data were analyzed using Prism 5 (GraphPad Software,
La Jolia, CA) and are shown as mean ± standard error
of the mean (SEM). Contractility studies were analyzed
by two-way analysis of variance (ANOVA) with aFigure 2. Ectopic expression of hM3Dq receptors in the in
Breeding scheme to generate double transgenic mice that exp
driven by the glial ﬁbrillary acidic protein (GFAP) promoter
element (TRE; tetO CMV) upstream of the hM3Dq recepto
absence of the tetracycline analog, doxycycline (dox) in thes
images of immunoreactivity for GFAP (glia, green, left pa
(grayscale, middle panels) in whole-mount preparations of m
the colons of GFAP::tTA/tetO::hM3Dq transgenic mice (overl
representative of labeling in a minimum of 3 animals from
tetO::hM3Dq, (C) GFAP::tTA78/tetO::hM3Dq, and (D) GFAP::t
all panels.Bonferroni post-test. Remaining data were analyzed by
Student t test. P < .05 was considered statistically
signiﬁcant.Results
Enteric glia respond to neurotransmitters6,11 and phys-
iologic patterns of neural activity in the ENS9 through GPCR
pathways that evoke intracellular Ca2þ responses.6,8 Yet
what role, if any, glial signaling downstream of intracellular
Ca2þ responses plays in the neural control of gut functions
is unknown. We addressed this issue directly by using a
chemogenetic approach22 to selectively trigger glial Ca2þ
responses and examining the effect on neuromuscular
transmission in the gut measured with in vivo and ex vivo
motility assays (Figure 1A).testines of GFAP::tTA/tetO::hM3Dq transgenic mice. (A)
ress the tetracycline-controlled transactivator protein (tTA)
and the tetracycline-responsive cytomegalovirus promoter
r. Note that glial cell hM3Dq transcription occurs in the
e lines. (B–D) Representative epiﬂuorescence microscopy
nels) and the hemagglutinin (HA)-tagged hM3Dq protein
yenteric plexus and the adherent longitudinal muscle from
ays of GFAP and HA shown in panels at right). Images are
each of the following transgenic lines: (B) GFAP::tTA67/
TA110/tetO::hM3Dq. Scale bar in D: 60 mM, and applies to
636 McClain et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6Functional Expression of hM3Dq “Designer
Receptors Exclusively Activated by Designer
Drugs” by Enteric Glia in GFAP::hM3Dq Mice
Our ﬁrst goal was to establish a suitable model to
selectively evoke reliable Ca2þ responses in enteric glial
cells. To this end, we obtained several chemogenetic mouse
lines (all transgenic) that express designer receptors
exclusively activated by designer drugs (DREADDs) under
transcriptional control of the glial ﬁbrillary acidic protein
(GFAP) promoter and tested their feasibility for use evoking
glial Ca2þ responses in the gut. We chose lines expressing
the hM3Dq variant of DREADD receptors because this
mutant GPCR activates the same canonical Gq signaling
pathway as endogenous glial GPCRs.6,8
These mouse lines included one line where hM3Dq is
constitutively expressed under the control of the GFAP
promoter23 (Figure 1B) and three double transgenic lines
that express the tetracycline-controlled transactivator pro-
tein (tTA) under regulatory control of the GFAP promoter24
and the tetracycline-responsive promoter element (TRE;
tetO) upstream of the hM3Dq receptor29 (Figure 2A). In
double mutant offspring of the latter “Tet-Off” system,
hM3Dq transcription occurs in the absence of the tetracy-
cline analog doxycycline. Speciﬁc details on mouse lines areprovided in the Materials and Methods section. We reasoned
that a suitable model should meet certain basic criteria
including 1) conﬁnement of hM3Dq receptor expression to
GFAP-positive enteric glia and 2) reliable Ca2þ responses
evoked in glia in response to the physiologically inert
hM3Dq agonist CNO.
All transgenic mouse lines tested express hM3Dq with a
hemagglutinin (HA) protein tag, and we took HA immuno-
reactivity as acceptable evidence for hM3Dq protein
expression and localization. In GFAP::hM3Dq transgenic
mice, we observed robust immunoreactivity for HA-tagged
hM3Dq that was conﬁned to GFAP-immunoreactive and
S100beta-immunoreactive enteric glia within the myenteric
plexus of the ileum and colon (Figure 1C–E and Figure 3).
HA-immunoreactivity was distributed across the surface of
all observable GFAP-immunoreactive and S100beta-
immunoreactive enteric glial cells and was never observed
in non-GFAP-immunoreactive cells such as neurons
(Figure 1F), interstitial cells of Cajal (Figure 1G), or smooth
muscle cells (Figure 1G). Likewise, HA immunoreactivity
was never observed in tissue from wild type (WT) litter-
mates of GFAP::hM3Dq transgenic mice (Figure 3). In
contrast to the GFAP::hM3Dq mice, we observed only weak
HA-immunoreactivity within the myenteric plexus of theFigure 3. Expression of
hM3Dq receptors is
conﬁned to enteric glia in
the intestines of GFAP::
hM3Dq mice. (A–D) Epi-
ﬂuorescence images of
immunoreactivity for en-
teric glia (glial ﬁbrillary
acidic protein [GFAP]
shown in green) and the
hemagglutinin (HA)-tagged
hM3Dq protein (grayscale)
in whole-mount longitudi-
nal muscle myenteric
plexus (LMMP) prepara-
tions from the colon (A, B)
and ileum (C, D) of GFAP::
hM3Dq transgenic mice
(A, C) and wild-type (WT)
littermates (B, D). Note
that HA-immunoreactivity
is conﬁned to GFAP-
immunoreactive glia in
GFAP::hM3Dq mice. Im-
ages are representative of
labeling in a minimum of
3 animals. Scale bar in D:
60 mM, and applies to all
panels.
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mice tested, and the pattern of HA labeling more closely
resembled that of nerve varicosities than glial cells
(Figure 2). This likely reﬂects ectopic expression due to
differing transgene insertion sites into the genome in these
lines. These data are consistent with previous work showing
that these speciﬁc lines of GFAP::tTA mice yield neuronal
expression in the cerebellum, forebrain, and spinal cord.24
Next, we tested the functionality of hM3Dq receptors
expressed by enteric glia by imaging intracellular Ca2þ
transients evoked by the hM3Dq agonist CNO (Figure 4).
Our results show that stimulation of hM3Dq with CNO
(10 mM)23 in tissue from GFAP::hM3Dq mice selectively
induces reliable intracellular Ca2þ responses within enteric
glia (Figure 4A, C, and D and Video 1) but has no effect on
cellular Ca2þ levels in tissue from WT littermatesFigure 4. Activation of glial hM3Dq receptors reliably evoke
tative traces of intracellular Ca2þ levels in myenteric glia in gan
(WT) littermates in response to the hM3Dq agonist clozapine-N-
cell and all glial cells within an individual ganglion are shown. (C
receptors with CNO (blue shaded area) in GFAP::hM3Dqmice eli
top) and cell bodies (black lines, bottom). (D) Representative im
GFAP::hM3Dq mouse at rest (baseline, top image) and after st
Traces are representative of recordings in n ¼ 6 ganglia from a(Figure 4B). Enteric glia from GFAP::hM3Dq mice and WT
littermates exhibited comparable purine-evoked Ca2þ re-
sponses (adenosine diphosphate [ADP], 100 mM, data not
shown), suggesting that the expression of endogenous re-
ceptor pathways is not signiﬁcantly altered in this trans-
genic line.
Glial responses to CNO in GFAP::hM3Dq mice are
characterized by large Ca2þ transients in glial cell bodies
(mean peak DF/F ¼ 1.35 ± 0.18, n ¼ 60 glial cells from six
ganglia, three animals) and many oscillating Ca2þ tran-
sients throughout glial processes (Figure 4C). In contrast
to GFAP::hM3Dq mice, we never observed glial Ca2þ
transients in response to CNO in tissue from any of the
three GFAP::tTA/tetO::hM3Dq lines of mice tested
(Figure 5). However, enteric glia in tissue from GFAP::tTA/
tetO::hM3Dq mice still exhibited robust purine-evokeds intracellular calcium (Ca2D) transients. (A, B) Represen-
glia from (A) GFAP::hM3Dq transgenic mice and (B) wild-type
oxide (CNO, 10 mM). Each trace represents an individual glial
) Representative traces showing that activation of glial hM3Dq
cits intracellular Ca2þ transients in glial processes (green lines,
ages of Fluo-4 ﬂuorescence in a myenteric ganglion from a
imulation with CNO (peak, bottom image). Scale bar: 10 mM.
t least three mice of each genotype.
Figure 5. Representative calcium (Ca2D) imaging of
myenteric glia in experimental lines (A) GFAP::tTA67/
tetO::hM3Dq, (B) GFAP::tTA78/tetO::hM3Dq, and (C)
GFAP::tTA110/tetO::hM3Dq. Each panel shows the activity
of all individual glial cells (black traces) within a myenteric
ganglion (averaged response of all glia within ganglion over-
laid in green). In all cases, application of clozapine-N-oxide
(CNO; 30 seconds, 50 mM) failed to elicit Ca2þ activity in glial
cells. These same cells exhibited robust elevations in intra-
cellular Ca2þ in response to adenosine diphosphate (ADP; 30
seconds, 100 mM).
638 McClain et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6intracellular Ca2þ responses (ADP, Figure 5). Together,
these results show that GFAP::hM3Dq mice are a suitable
model system to study the effects of selectively evoking
glial Ca2þ responses and we proceeded to use this line for
all additional studies.Enteric Glial Cell Calcium Signaling Driven by
Gq-G Protein-Coupled Receptors Triggers
Neurogenic Smooth Muscle Contractions
Calcium responses in enteric glia are mainly reported in
myenteric circuits controlling gut contractility. Thus, we
initially tested whether the activation of glial Ca2þ signaling
alone has any effect on intestinal contractility. To this end,
we conducted isometric muscle tension recordings in
longitudinally oriented segments of intestine and selectively
triggered glial Ca2þ responses with CNO in tissue from
GFAP::hM3Dq mice (Figure 6).
Application of CNO (10 mM) elicited large contractions
in segments of ileum and colon from GFAP::hM3Dq mice
(Figure 6A and B) but had no effect on tissue from WT
littermates (Figure 6C and D). Contractions elicited by
CNO were equal in magnitude to those driven by the direct
stimulation of smooth muscle with bethanechol (Figure 6E
and F, BCH, 10 mM) and equal in magnitude to those
driven by maximal stimulation of ENS neurons with EFS
(20 Hz, 20 V; Figure 6E and F). Contractions driven by CNO
were entirely dependent upon neuronal activation
because they were absent in the presence of tetrodotoxin
(Figure 6A and B, TTX). BCH and EFS elicited equal con-
tractions in bowel segments from GFAP::hM3Dq and WT
mice, indicating that the transgenic mice do not have any
gross abnormalities in the excitability of enteric neurons
and/or the ability of intestinal smooth muscle to contract
(Figure 6E and F).
EFS induced neurogenic relaxations in segments of ileum
and colon precontracted with PGF2a (Figure 7). CNO had no
effect on neurogenic relaxations in either WT or
GFAP::hM3Dq mice (Figure 7). In addition, CNO did not
stimulate neurogenic relaxations in the absence of EFS
(Figure 7A–D). Together, these results show that glial
stimulation predominantly affects excitatory motor circuits
controlling gut contractions and that glial stimulation has
little or no effect on inhibitory circuits regulating gut
relaxations.
Stimulation of Enteric Glial Cell Calcium Signaling
Enhances Colonic Migrating Motor Complexes
Fecal pellet propulsion in mice is driven by an enteric
neural reﬂex that manifests as a rhythmic migrating motor
pattern in the isolated large intestine called the colonic
migrating motor complex (CMMC).30,31 Enteric glial cell
Ca2þ responses are entrained with neuronal activity during
the CMMC,9 but their signiﬁcance remains unclear. There-
fore, we tested how the activation of glial Ca2þ signaling
affects the ongoing pattern of the CMMC in the isolated
colon (Figure 8).
We observed spontaneous, regular CMMCs in both
GFAP::hM3Dq transgenic mice and WT littermates as
contractions migrating from proximal to distal colon that
were separated by periods of quiescence. Baseline CMMC
activity was comparable between GFAP::hM3Dq mice and
WT littermates, and we did not observe any differences in
contractile activity or overall propagation characteristics
of CMMCs between genotypes in the absence of CNO. Upon
Figure 6. Selective acti-
vation of glial calcium
(Ca2D) responses elicits
neurogenic contractions
of intestinal smooth
muscle. (A–D) Represen-
tative isometric muscle
tension recordings of seg-
ments of ileum and colon
from (A, B) GFAP::hM3Dq
transgenic mice and (C, D)
WT littermates. Note that
clozapine-N-oxide (CNO;
10 mM, blue traces),
bethanechol (BCH; 10 mM,
black traces), and electrical
ﬁeld stimulation (EFS; 20 V,
0.1 ms, 20 Hz, purple
traces) (A, B) elicit com-
parable contractions in
the intestines of GFAP::
hM3Dq transgenic mice
and (C, D) that CNO has no
effect on the contractility of
tissue from wild-type (WT)
littermates. Contractions
elicited by CNO in GFAP::
hM3Dq mice are abolished
in the presence of tetro-
dotoxin (TTX, 0.3 mM, red
dashed trace in A, B). (E, F)
Summary data of contrac-
tions measured in res-
ponse to CNO, BCH, and
EFS in tissue from GFAP::
hM3Dq transgenic mice
and WT littermates (n ¼
5–7, *P < .05, **P < .01,
two-way analysis of
variance).
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alteration in the properties of the CMMCs in GFAP::hM3Dq
mice but no signiﬁcant changes in the CMMCs of WT lit-
termates (Figure 8A, B, and D). Overall, we observed a
signiﬁcant enhancement of all contractile parameters of
the CMMC after glial activation including increased
CMMC frequency (by 25.8%), propagation velocity (by
55.5%), amplitude (oral by 12.6%, aboral by 13.5%), and
integral (oral by 21.4%, aboral by 17.7%) (Figure 9).
These results show that glial Ca2þ signaling functions to
enhance excitatory neural circuits that control the CMMC
in mice.Stimulation of Enteric Glial Cell Ca2þ Signaling
Augments Gastrointestinal Motility in Vivo
Our results show that glial mechanisms downstream of
Ca2þ signaling can activate neural circuits that drive
neurogenic contractions of intestinal smooth muscle and
that glial Ca2þ signaling enhances neural circuits thatdrive CMMCs. We hypothesized these effects observed in
ex vivo preparations would correspond to an overall
enhancement of gut motility in vivo. To this end, we
triggered glial Ca2þ signaling in vivo with a single injection
of CNO in GFAP::hM3Dq mice and assessed several mea-
sures of gut motility (Figure 10). After administration of
CNO, we observed a nearly threefold increase in the
number of fecal pellets produced per hour by
GFAP::hM3Dq mice as compared to their WT littermates
(Figure 10A). Despite enhancing the number of pellets
produced, we found that the composition of water and
fecal matter in the pellets produced remained comparable
(Figure 10B).
To more accurately measure colonic transit, we
measured the latency to expel a small plastic bead
inserted into the distal colon. Similar to the enhancement
of endogenous pellet production, the administration of
CNO decreased the time required to expel the bead by
nearly two-thirds in GFAP::hM3Dq mice as compared to
their WT littermates (Figure 10C). However, the activation
Figure 7. Glial stimulation
has no effect on neuro-
genic relaxations. (A, B)
Representative traces
showing neurogenic re-
laxations elicited by elec-
trical ﬁeld stimulation (EFS)
(20 V; 0.1 ms; 20 Hz, pur-
ple traces) in prostaglandin
F2a-precontracted, longi-
tudinally oriented seg-
ments of ileum (A, C) and
colon (B, D) from GFAP::
hM3Dq transgenic mice
(A, B) and wild-type (WT)
littermates (C, D). All re-
laxations are abolished in
the presence of tetrodo-
toxin (TTX, 0.3 mM, red
dashed traces in A-B).
Clozapine-N-oxide (CNO)
alone (10 mm; blue traces in
A–D) does not stimulate
relaxations in precontracted
segments of intestine and
has no effect on neurogenic
relaxations driven by EFS
in WT or GFAP::hM3Dq
mice (gray traces in A–D).
(E, F) Summary data of
relaxations measured in
response to EFS in the
presence and absence of
CNO in tissue from GFAP::
hM3Dq transgenic mice
and WT littermates (n ¼
5–7, P > .05, two-way
analysis of variance).
640 McClain et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6of glial Ca2þ signaling did not signiﬁcantly alter whole
intestinal transit time or small intestinal transit velocity in
GFAP::hM3Dq mice (Figure 10D and E). Together, these
results indicate that glial excitation triggering Ca2þ
signaling activates excitatory neural programs in the
colon.Discussion
Enteric glial cells have been recognized as the sole
companions of neurons within enteric ganglia since the
earliest studies of the ENS,32 and our current under-
standing of the neural control of gut reﬂexes stems from
the assumption that there is a clear division of labor be-
tween neurons and glia. Indeed, glial cells are widely
considered silent in terms of the synaptic physiology un-
derlying gut reﬂexes33 and are thought to play more sig-
niﬁcant roles in the metabolic support of these neuronal
circuits.2 However, recent experimental ﬁndings showing
that enteric glia display a form of excitability encoded byelevations in intracellular Ca2þ suggest that this division
many not be as straightforward as once thought.6–9,11
Indeed, results showing that glial Ca2þ responses are
evoked by a variety of neuromodulators11 including those
released by neurons during physiologic pattern of ENS
activity9 have raised the controversial possibility that glial
cells actively participate in information transfer in enteric
circuits. Yet the outcomes of glial Ca2þ signaling have
thus far remained unclear despite intense interest in
observing glial Ca2þ signaling in response to various
mediators.10
Our goal in the present study was to clarify the signiﬁ-
cance of evoked glial Ca2þ signaling in the regulation of
intestinal motility. To this end, we used a novel transgenic
chemogenetic mouse model to selectively evoke glial Gq-
GPCR signaling leading to intracellular Ca2þ responses.23
Our results show that evoked glial Ca2þ signaling has a
strong, excitatory effect on enteric motor circuits. Glial
excitation enhanced ongoing patterns of ENS activity such as
the CMMC and glial excitation per se was sufﬁcient to drive
Figure 8. Selective activation of glial calcium (Ca2D) transients enhances the colonic migrating motor complex (CMMC)
in GFAP::hM3Dq transgenic mice. Representative (A) oral and (B) aboral recordings of CMMCs in GFAP::hM3Dq mice (black
traces) and WT littermates (gray traces) under basal conditions (solid lines) and after glial activation with clozapine-N-oxide
(CNO) (dashed lines). (C) Model of experimental setup for CMMC recordings. (D) Frequency distribution of CMMC propagation
initiation point in wild-type and GFAP::hM3Dq transgenic mice in the presence or absence of CNO (n ¼ 3–5, two-way analysis
of variance).
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is quite astounding because it suggests that glial excitation
may play an important role in the initiation of speciﬁc motor
programs in the gut. Given the present results, it is
conceivable that glial excitation initiated by neuronal
signaling functions to ‘call up’ certain motor programs and
distributes this message through the glial network. Whether
the motor programs of digestion are stored in glial networks
is certainly still a hypothetical question, but it will be an
intriguing issue addressed in future work.
Precisely how glial Ca2þ signaling is translated into
neuronal excitation in the ENS is unknown and will likely
remain an active area of research for quite some time.
Likewise, the downstream effects of astrocytic Ca2þ
signaling remain a matter of great controversy.19 Several
models have been put forth to account for the effects of glia
on central networks. Given that enteric glia share many
similarities with astrocytes, we speculate that enteric glia
modulate enteric neuronal networks using similar mecha-
nisms. The most promising of these include the release of“gliotransmitters”34 and the active control of extracellular
potassium (Kþ) ion concentration.35
Either mechanism, or both, could contribute to the
effects we observed upon glial activation in the gut by
directly activating excitatory circuits with excitatory
gliotransmitters36 or by decreasing the inhibiting tone by
decreasing extracellular Kþ37 and hyperpolarizing inhib-
itory neurons. We feel that the most likely explanation for
our current data is that glial stimulation drives the release
of an excitatory mediator that stimulates one, or all of
the following classes of myenteric neurons: excitatory
ascending interneurons, excitatory motorneurons, or
intrinsic primary afferent neurons. Excitation of any one
or combination of these neuron classes could produce the
observed result on neurogenic contractions. Importantly,
we did not observe any noticeable effect of glial excitation
on neurogenic relaxations. This outcome strongly sug-
gests that glia regulate neurotransmission on a synapse-
by-synapse basis and not by the diffuse release of
neuroactive compounds that broadly affect all types of
Figure 9. Activation of glial calcium (Ca2D) signaling enhances key aspects of colonic migrating motor complexes
(CMMCs). (A–F) Summary data of CMMC characteristics including oral contraction (A) amplitude and (B) integral, (C) CMMC
frequency, aboral contraction (D) amplitude and (E) integral, and (F) propagation velocity. All data are expressed as per-
centage change from baseline after the addition of clozapine-N-oxide. (n ¼ 3–5, *P < .05, **P < .01, ***P < .001, two-tailed
t-test).
642 McClain et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 6neurons. Thus, mechanisms downstream of glial Ca2þ
signaling appear to not necessarily set the tone of
neurotransmission but rather to play an active role in the
modulation of speciﬁc neuronal circuits controlling the
contractile aspect of gut motility. However, more work is
clearly needed to decipher the exact mechanisms
involved.
Interestingly, our in vivo data suggest that the role of
glial Ca2þ signaling could differ between gut regions. For
example, we observed a marked increase in colonic transit
but no change in whole gut transit or small intestinal
transit. However, our ex vivo data show that the activation
of glial Ca2þ signaling evokes similar contractions in seg-
ments of ileum and colon. One explanation for these re-
sults is that there is signiﬁcant glial heterogeneity along
the length of the gastrointestinal tract.38,39 Thus, it is
conceivable that the different populations of enteric glia
have different roles in synaptic transmission. However, a
more likely explanation lies in the fact that in vivo motility
patterns and neural innervation differ signiﬁcantly be-
tween the ileum and colon.40 The fact that glial excitation
elicited similar contractions in segments of ileum and
colon in vitro strongly suggests that glial excitation has a
similar effect on enteric circuits in both organs. In vivo,
motility patterns in the small intestine are heavily inﬂu-
enced by central pathways, and the concomitant activation
of enteric and central glia could confound clear results in
this region of gut. In contrast, extrinsic innervation playsless of a role in colonic motility, and the effects we observe
in this organ likely reﬂect a more pure stimulation of
enteric glial cells.
In addition to differing between gut regions, the role of
glial Ca2þ signaling appears to differ signiﬁcantly between
the myenteric and submucosal plexuses. In our hands, we
did not observe a major effect of glial stimulation on the
ﬂuid content of fecal matter. In agreement, MacEachern
et al41 found that the gliotoxin ﬂuoroacetate had no effect
on electrogenic ion transport in the colon. Based on their
ﬁndings, these investigators concluded that enteric glia do
not play a role in the regulation of electrogenic ion trans-
port in the gut under physiologic conditions. Our current
data would support this conclusion in that we show that
glial Ca2þ signaling does not play a major role in the
regulation of ﬂuid exchange in the colon on an acute time
scale. However, many other glial signaling mechanisms that
do not rely on ﬂuxes of intracellular Ca2þ may play
important roles in the regulation of ﬂuid exchange, and
investigating these alternate signaling pathways will be
important to understand the integrated function of glia in
the intestine.
Together, our results provide a framework for under-
standing the consequences of glial excitation in the form
of Ca2þ signaling in past and future work. Importantly,
our results show that the activation of glia can have
profound effects on gut physiology. This is particularly
important when considering disorders such as chronic
Figure 10. Selective acti-
vation of enteric glial
calcium (Ca2D) signaling
in vivo enhances gastro-
intestinal motility. Effect
of the hM3Dq agonist clo-
zapine-N-oxide (0.25 mg
kg1, intraperitoneal) on (A)
endogenous pellet pro-
duction, (B) fecal pellet
composition, (C) colonic
transit time, and (D) whole-
gastrointestinal transit time
and (E) upper gastrointes-
tinal transit velocity in
GFAP::hM3Dq transgenic
mice and WT littermates
(n ¼ 4–5, **P < .01, ***P <
.001, two-tailed t-test).
November 2015 Glial Ca2+ Signaling and Excitatory Motor Programs 643constipation and other functional gastrointestinal disor-
ders where the glial network is disrupted.42 In these
conditions, modifying glial activity could prove to be an
extremely effective and novel therapeutic strategy to
restore gut motility.References
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